Adaptimmune vs Autolus Therapeutics
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer
200 employees · est. 2008 · Abingdon, United Kingdom
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
720 employees · est. 2014 · London, United Kingdom
Adaptimmune is the older company (2008 vs 2014); Autolus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Adaptimmune | Autolus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2014 |
| Headquarters | ||
| Headquarters | Abingdon, United Kingdom | London, United Kingdom |
| Employees | ||
| Employees | 200 | 720 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post-IPO Debt | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $499.50M | $1.07B |
| Funding Rounds | ||
| Funding Rounds | 9 | 10 |
| Services | ||
| Services | Development of T-cell therapies, Pipeline management of cell therapies, Sale and licensing of cell therapies, Biotechnological research, Clinical trials | Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Biopharmaceutical companies, Medical researchers | Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions |
| Taxonomy | ||
| Taxonomy | Cell TherapyCancer TreatmentT Cell TherapiesPreclinical ResearchClinical DevelopmentTranslational Sciences +8 | CAR T Cell TherapyT Cell ProgrammingCancer TreatmentAutologous T Cell TherapiesNext-generation TherapiesObe-cel (obecabtagene Autoleucel) +9 |
| Website | ||
| Website | adaptimmune.com | autolus.com |
About Adaptimmune
Adaptimmune stands as a pioneering entity in the biopharmaceutical landscape, specializing in cell therapies designed to revolutionize cancer treatment. With its strong presence in four biotechnology hubs across the U.K. and U.S., the company showcases comprehensive competencies ranging from preclin...
About Autolus Therapeutics
Autolus Therapeutics, founded in 2014, is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries. Based in the United Kingdom, the company is renowned for its innovative approach towards cancer treatment, with a clear focus on developing precisely targeted and highly con...
Also comparing in this category
Comparing more than these two?
Get Adaptimmune, Autolus Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Adaptimmune compare?
A PDF of Adaptimmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Adaptimmune with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Adaptimmune on 11 Mar 2026, and Autolus Therapeutics on 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
